Growth Metrics

Immuron (IMRN) Receivables - Other (2016 - 2025)

Immuron's quarterly Receivables - Other came in at $15170.6 in Q2 2025, down 17.79% year-on-year from $18452.7 in Q2 2024, and down 28.58% quarter-over-quarter from $21241.8 in Q4 2024.

Immuron has reported Receivables - Other for 5 years, with the latest figure at $15170.6 in Q2 2025.

  • For the quarter ending Q2 2025, Receivables - Other fell 17.79% year-over-year to $15170.6; the trailing twelve-month figure through Jun 2025 stood at $15170.6 (down 17.79% YoY), and the FY2025 full-year result was $15352.9, down 16.4% from the prior year.
  • Receivables - Other for Q2 2025 stood at $15170.6, down from $21241.8 in the prior quarter.
  • The five-year high for Receivables - Other was $1.1 million in Q2 2023, with the low at $15170.6 in Q2 2025.
  • Average Receivables - Other over 3 years is $283134.7, with a median of $19847.3 recorded in 2024.
  • Year-over-year, Receivables - Other tumbled 98.29% in 2024 and fell 17.79% in 2025.
  • Tracing IMRN's Receivables - Other over 3 years: stood at $1.1 million in 2023, then sank by 98.03% to $21241.8 in 2024, then slipped by 28.58% to $15170.6 in 2025.
  • The last three Receivables - Other figures came in at $15170.6 (Q2 2025), $21241.8 (Q4 2024), and $18452.7 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Immuron 1.27 Bn 1.27 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 15,170.58
Jun 30, 2025 15,170.58
Dec 31, 2024 21,241.82
Dec 31, 2024 21,241.82
Jun 30, 2024 18,452.69
Jun 30, 2024 18,452.69
Jun 30, 2023 1.08 Mn
Jun 30, 2023 1.08 Mn
Jun 30, 2019 96,785.66
Jun 30, 2019 96,785.66
Jun 30, 2016 1.95 Mn
Jun 30, 2016 1.95 Mn